DrugBaron

JANUARY 31, 2024

Billions of dollars have been invested in companies promising to “revolutionise pharma R&D” through the application of artificial intelligence – but it is now clear that global pharma companies, and not just tech bro’s, are buying into the claims. And there is no doubt that there is plenty of room for improvement.

Pharma R&D 165

Pharma R&D Science Small Molecule Drugs 165

PPD

JULY 13, 2023

Site and patient recruitment vendors are vital in supporting clinical trial operations across all phases and therapeutic areas. Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Clinical Research 52

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.” billion and taking upwards of 15 years.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

biobide

FEBRUARY 2, 2024

This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes. This treatment was developed by performing a chemical screening on zebrafish.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

Metabolite Tales Blog

DECEMBER 19, 2023

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group A Metabolite Bioanalysis Working Group comprised of experts from 14 different pharma companies have proposed recommendations around best practice in metabolite bioanalysis during drug development.

Pharma Companies 52

Pharma Companies Drug Development Trials Compliance 52

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. She has held leadership positions in Project Management, Technical Operations, and Business Development.

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. The fund is already starting off with more than $50 million in initial capital. .

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Codon

FEBRUARY 13, 2024

Many pathogenic bacteria have not just developed resistance to the most common drug used to treat them — known as antimicrobial resistance or AMR; they have become multi-drug resistant (MDR), extensively drug-resistant (XDR), or pan-drug resistant (PDR) — the latter meaning they are resistant to every drug we have in the cabinet.

Therapies 124

Therapies Virus DNA Clinical Trials 124

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. By geographical region, the global CRO services market in 2023 was dominated by North America.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

The Pharma Data

NOVEMBER 10, 2020

When a company engages a CRO, they most often turn over full control of their study or preclinical trials to this contractor – in other words, they “outsource” their research. By giving companies full control of their studies, they are able to significantly speed up timelines,” Tessier said. The People Side.

Marketing 52

Marketing Science Pharma Companies Research 52

Vial

FEBRUARY 19, 2024

The neat thing about it, it was an oral drug that can inhibit a specific receptor on the B cells that are causing different types of leukemia and lymphoma. As we put it in first in human (trials), and we saw responses, it was super exciting to be able to navigate the landscape and where to position it for the patient benefit.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

H1 Blog

DECEMBER 11, 2024

These forecasts highlight the key changes poised to transform the healthcare and pharma landscapes. In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Additionally, well see a move to multi-indication trials to maximize profitability.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Altus Drug Development

JUNE 28, 2022

For example, the chemical compound Thalidomide, which was created via drug repurposing, can be used in the treatment of HIV, various forms of cancer, and skin conditions like complications associated with leprosy. Drug repositioning has become a strategic research approach when treating neglected diseases.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

DECEMBER 30, 2020

In September 2020, the trials were halted to investigate a potentially severe side effect in a UK patient, transverse myelitis, an inflammation of part of the spinal cord. After a short break, the trial restarted in the UK and other parts of the world, but was delayed for much longer in the U.S. With a market cap of $1.6

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug Target Review

MARCH 13, 2025

Planning the journey from data to deliverables The future of AI-enabled drug development benefits from the continued advancement of multimodality and clinical genomics, with a focus on integration, efficiency and personalisation to transform both care and R&D. Techbio companies have initiated this approach.

Drug Development 52

Drug Development Science Clinical Trials FDA 52

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In the end, counsel urged that imposing undue liability would discourage drug development. In Gilead v. Superior Court , No. A165558 (Cal.

Production 64

Production Marketing Drugs Pharma Companies 64